Report Categories

Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20–24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval.

USD4480.00

Add To Cart

Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20–24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval.

USD3480.00

Add To Cart

The global Small Interfering RNA (siRNA) Drugs market size is expected to reach $ 5308.7 million by 2030, rising at a market growth of 26.3% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Small Interfering RNA (siRNA) Drugs market size was valued at USD 1035.6 million in 2023 and is forecast to a readjusted size of USD 5308.7 million by 2030 with a CAGR of 26.3% during review period.

USD3480.00

Add To Cart

The siRNA Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart

The global siRNA Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

The global Small Interfering RNA (siRNA) Drugs market size is expected to reach $ 5308.7 million by 2029, rising at a market growth of 26.3% CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Small Interfering RNA (siRNA) Drugs market size was valued at USD 1035.6 million in 2022 and is forecast to a readjusted size of USD 5308.7 million by 2029 with a CAGR of 26.3% during review period.

USD3480.00

Add To Cart

The siRNA Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart